Summary
Tabula Rasa HealthCare, Inc. operates as a healthcare technology company in the United States. The company operates in two segments, CareVention HealthCare and MedWise HealthCare. It offers EireneRx, a cloud-based medication decision-support and e-prescribing platform to access patient medication-related information; and MedWise medication therapy management software, a cloud-based platform designed to aid in the identification and resolution of medication and health-related problems. The company also provides TruChart that offers electronic health records (EHR), care coordination, and financial management in one program allowing Programs of All-Inclusive Care for the Elderly (PACE) to track measurable outcomes in defined timeframes for the populations they serve; and PACElogic, which delivers sharable workflows comprising EHR, customer relationship management, claims adjudication, electronic data interchange, care management, coordination and planning, integration with community-based providers, and various federal and state that requires reporting. In addition, it offers DoseMeRx, a decision support software that leverages clinically validated pharmacokinetic drug models, patient characteristics, drug concentrations, and genotypes to guide dose optimization; and PrescribeWellness, a PrescribeWellness, a patient engagement center platform. Further, the company provides clinical pharmacist collaboration, prescription fulfillment and adherence packaging, and pharmacy benefit management services, as well as health plan management services, including risk adjustment and third party administrator services. As of December 31, 2021, it served approximately 150 healthcare organizations; and 350 health plans and approximately 18,000 retail pharmacies. The company provides cloud-based software applications to assist prescribers and pharmacists. Tabula Rasa HealthCare, Inc. was founded in 2009 and is headquartered in Moorestown, New Jersey.
History
TRHC was founded in 2008 as a demonstration project with early seed funding from National Institutes of Health. In 2009, TRHC received its first round of private equity funding and in 2011 became publicly traded. TRHC continues to evolve, with a focus on advancing healthcare through the delivery of medication adherence services and technology fueled by patient medication data.
Mission
Tabula Rasa HealthCare's mission is to offer best-in-class medication risk management technology to improve the medication adherence, health outcomes, and cost of care for our customers and their patients.
Vision
Tabula Rasa HealthCare's vision is to be the leader in providing healthcare organizations with the most advanced technology to reduce medication risks.
Key Team
Ms. Andrea Carolan Speers M.S. (Corp. Controller & Chief Accounting Officer)
Mr. Bob Sullivan M.S. (Chief Technology Officer)
Ms. Kathleen D Larkin M.B.A. (Chief People Officer)
Mr. Phillip W. Heath MS (Chief Admin. Officer)
Mr. Frank Sparacino C.F.A., CPA (Sr. VP of Investor Relations & Corp. Devel.)
Mr. Brian J. Litten J.D. (Chief Strategic Growth Officer)
Mr. Kevin J. Dill DMIN, J.D. (Gen. Counsel)
Recognition and Awards
Tabula Rasa HealthCare has been recognized by numerous organizations for its services and technology, such as the 2016 INC 5000’s Fastest Growing Private Companies, winner of the ‘2015 Deloitte Technology Fast 500 Award’ for being one of the fastest growing companies in North America, and the 2016 IBM Watson Award for Healthcare Innovation.
References
